Inventor · disambiguated record
Eric Carlson
Also filed as: CARLSON ERIC · CARLSON ERIC C
12 granted patents·9 pending applications·92 citations·filing 2006–2023
89Inventor score
Files withEISAI R&D MAN CO LTD7OYSTER POINT PHARMA INC4AERIE PHARMACEUTICALS INC3ALCON RES LTD3BOIVIN ROCH1
Top patents by PatentIndex Score
21 records- 0197US9428495B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2014·Granted Aug 30, 2016·35 cites·32 claims
- 0293US9126999B2Tetrahydropyrazolopyrimidine compoundsBOIVIN ROCH·Filed 2013·Granted Sep 8, 2015·33 cites·28 claims
- 0390US9446046B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2015·Granted Sep 20, 2016·8 cites·6 claims
- 0485US7666875B2Hydantoin compoundsEISAI R&D MAN CO LTD·Filed 2006·Granted Feb 23, 2010·11 cites·30 claims
- 0584US11059789B2Isoquinoline-steroid conjugates and uses thereofAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jul 13, 2021·1 cites·30 claims
- 0683US10640500B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2017·Granted May 5, 2020·1 cites·5 claims
- 0783US9850242B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2016·Granted Dec 26, 2017·3 cites·12 claims
- 0870US11130758B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2020·Granted Sep 28, 2021·0 cites·9 claims
- 0969US11691950B2Isoquinoline-steroid conjugates and uses thereofAERIE PHARMACEUTICALS INC·Filed 2021·Granted Jul 4, 2023·0 cites·18 claims
- 1064US2025352668A1Aav vector encoding diamine oxidase and uses thereofOYSTER POINT PHARMA INC·Filed 2023·Application pending·0 cites
- 1160US2016326161A1Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2016·Application pending·0 cites
- 1259US12268663B2Method for treating pruritusPRUVYC PHARMA LLC·Filed 2021·Granted Apr 8, 2025·0 cites·13 claims
- 1359US2024238375A1Aav virion encoding neurotrophic factor and uses thereofOYSTER POINT PHARMA INC·Filed 2022·Application pending·0 cites
- 1458US2023210861A1Local administration of nicotinic acetylcholine receptor agonists for the inhibition of coronavirus infectionsOYSTER POINT PHARMA INC·Filed 2022·Application pending·0 cites
- 1556US2024226109A1Co-therapy with vector and nicotinic agonistOYSTER POINT PHARMA INC·Filed 2022·Application pending·0 cites
- 1652US2011207809A1Method of accelerating corneal wound healingALCON RES LTD·Filed 2011·Application pending·0 cites
- 1752US2014228430A1Method of Accelerating Corneal Wound HealingALCON RES LTD·Filed 2014·Application pending·0 cites
- 1851US2013274216A1Treatment for microbe-induced inflammatory responses in the eyeALCON RES LTD·Filed 2013·Application pending·0 cites
- 1950US11117869B2Compounds, compositions and methods for treatment of myopiaAERIE PHARMACEUTICALS INC·Filed 2020·Granted Sep 14, 2021·0 cites·2 claims
- 2039US2010113446A1Hydantoin compoundsGALLAGHER JR BRIAN M·Filed 2010·Application pending·0 cites
- 2136US10537648B2Compositions and methods for visualization of the vitreousNOVARTIS AG·Filed 2015·Granted Jan 21, 2020·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Eric Carlson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →